New Zealand markets closed

Regen BioPharma, Inc. (RGBP)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.7400+0.0400 (+5.71%)
At close: 03:12PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.63M
Enterprise value 3.22M
Trailing P/E 31.20
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)10.64
Price/book (mrq)N/A
Enterprise value/revenue 13.59
Enterprise value/EBITDA -4.20

Trading information

Stock price history

Beta (5Y monthly) 2.79
52-week change 3-58.43%
S&P500 52-week change 322.64%
52-week high 32.5500
52-week low 30.4010
50-day moving average 30.7618
200-day moving average 31.2339

Share statistics

Avg vol (3-month) 314.6k
Avg vol (10-day) 310.23k
Shares outstanding 53.75M
Implied shares outstanding 63.75M
Float 83.75M
% held by insiders 10.01%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:1500
Last split date 306 Mar 2023

Financial highlights

Fiscal year

Fiscal year ends 30 Sept 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-207.88%

Management effectiveness

Return on assets (ttm)-75.37%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)236.56k
Revenue per share (ttm)0.07
Quarterly revenue growth (yoy)0.00%
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-774.69k
Diluted EPS (ttm)-0.2600
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)124.5k
Total cash per share (mrq)0.03
Total debt (mrq)714.07k
Total debt/equity (mrq)N/A
Current ratio (mrq)0.03
Book value per share (mrq)-1.40

Cash flow statement

Operating cash flow (ttm)-325.79k
Levered free cash flow (ttm)31.99k